Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 270, Issue 1 39-1, 1996, Pages

  Morbidelli, Lucia ^b   Chang, Chung H O ^b   Douglas, Janice G ^b   Granger, Harris J ^b   Ledda, Fabrizio ^b   Ziche, Marina ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b NONE

Author keywords

angiogenesis; growth factor; guanosine 3',5' cyclic monophosphate

Indexed keywords

ARGININE; BASIC FIBROBLAST GROWTH FACTOR; CYCLIC GMP; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; RECOMBINANT PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0030042761     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.270.1.h411     Document Type: Article

References (33)

1. Breier, G., U. Albrecht, S. Sterrer, and W. Risau. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development Camb. 114 521-532, 1992.
2. 2+ and von Willebrand factor release in human endothelial cells. Am. J. Pathol. 138: 213-221, 1991.
3. Buga, G. M., M. E. Gold, J. M. Fukuto, and L. J. Ignarro. Shear stress-induced release of nitric oxide from endothelial cells grown on beads Hypertension Dallas 17: 187-193, 1991.
4. Clark, E. R., and E. L. Clark. Microscopic observations on the growth of blood capillaries in the living mammal. Am. J. Anat. 64: 251-299, 1939.
5. Conn, G., M. Bayne, L. Soderman, P. W. Kwok, K. A. Sullivan, T. M. Palisi, D. A. Hope, and K. A. Thomas. Amino acid and cDNA sequence of a vascular endothelial cell mitogen homologous to platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 87: 2628-2633, 1990.
6. Cooke, J. P., E. Rossitch, Jr., N. A. Andon, L. Loscalzo, and V. J. Dzau. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J. Clin. Invest 88: 1663-1671, 1991.
7. De Vries, C., J. A. Escobedo, H. Ueno, K. Houck, N. Ferrara, and L. T. Williams. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science Wash. DC 255: 989-991, 1992.
8. Ferrara, N., and W. J. Henzel. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161: 851-858, 1989.
9. Ferrara, N., K. Houck, L. Jakeman, and D. W. Leung. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13: 18-32, 1992.
10. Folkman, J. Angiogenesis. initiation and control. Ann. NY Acad. Sci. 401: 212-227, 1982.
11. Fong, G. H., J. Rossant, M. Gertsenstein, and M. L. Breitman. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature Lond. 376: 66-70, 1995.
12. Gospodarowicz, D., J. A. Abraham, and J. Schilling. Isolation and identification of a vascular endothelial mitogen produced by pituitary-derived follicular stellate cells. Proc. Natl. Acad. Sci. USA 86: 7311-7315, 1989.
13. Hu, D. E., and T.-P. D. Fan. Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A. Br. J. Pharmacol. 114: 262-268, 1995.
14. Hudlicka, O. Capillary growth: role of mechanical factors. News Physiol. Sci. 3: 117-120, 1988.
15. Hudlicka, O. What makes blood vessels grow? J. Physiol. Lond. 444: 1-24, 1991.
16. Jun, C. D., Hoon-Ryu, J. Y. Um, T. Y. Kim, J. M. Kim, S. S. Kang, H. M. Kim, and H. T. Chung. Involvement of protein kinase C in the inhibition of nitric oxide production from murine microglial cells by glucocorticoid. Biochem. Biophys. Res. Commun. 199: 633-638, 1994.
17. Ku, D. D., J. K. Zaleski, S. Liu, and T. A. Brock. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H586-H592, 1993.
18. Leibovich, S. J., P. J. Polverini, T. W. Fong, L. A. Harlow, and A. E. Koch. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc. Natl. Acad. Sci. USA 91: 4190-4194, 1994.
19. Millauer, B., S. Wizigmann-Voos, H. Schnurch, R. Martinez, N. P. H. Moller, W. Risau, and A. Ullrich. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72: 835-846, 1993.
20. Moncada, S., and A. Higgs. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329: 2002-2012, 1993.
21. Myoken, Y., Y. Kayada, T. Okamoto, M. Kan, G. H. Sato, and J. D. Sato. Vascular endothelial growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc. Natl. Acad. Sci. USA 88: 5819-5823, 1991.
22. Olander, J. V., D. T. Connolly, and J. E. DeLarco. Specific binding of vascular permeability factor to endothelial cells. Biochem. Biophys. Res. Commun. 175: 68-76, 1991.
23. Plate, K. H., G. Breier, B. Millauer, A. Ullrich, and W. Risau. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res. 53: 5822-5827, 1993.
24. Plate, K. H., G. Breier, H. A. Weich, and W. Risau. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature Lond. 359: 845-848, 1992.
25. Senger, D. R., S. J. Galli, A. M. Dvorak, C. A. Peruzzi, V. S. Harvey, and H. F. Dvorak. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascite fluid. Science Wash. DC 219: 983-985, 1983.
26. Shalaby, F., J. Rossant, T. P. Yamaguchi, M. Gertsenstein, X. F. Wu, M. L. Breitman, and A. C. Shuh. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature Lond. 376: 62-66, 1995.
27. Shweiki, D., A. Itin, D. Soffer, and E. Keshet. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature Lond 359: 843-845, 1992.
28. Terman, B. I., M. Dougher-Vermazen, M. E. Carrion, D. Dimitrov, D. C. Armellino, D. Gospodarowicz, and P. Bhlen. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem. Biophys. Res. Commun. 187: 1579-1586, 1992.
29. Wu, G., and C. J. Meininger. Regulation of L-arginine synthesis from L-citrulline by L-glutamine in endothelial cells. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H1965-H1971, 1993.
30. Ziada, A. M. A. R., O. Hudlicka, K. R. Tyler, and A. J. A. Wright. The effect of long-term vasodilatation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc. Res. 18: 724-732, 1984.
31. Ziche, M., L. Morbidelli, E. Masini, S. Amerini, H. J. Granger, C. A. Maggi, P. Geppetti, and F. Ledda. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94: 2036-2044, 1994.
32. Ziche, M., L. Morbidelli, E. Masini, H. J. Granger, P. Geppetti, and F. Ledda. Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. Biochem. Biophys. Res. Commun. 192: 1198-1203, 1993.
33. Ziche, M., D. Zawieja, and H. Granger. Calcium entry, mobilization and extrusion in postcapillary venular endothelium. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H569-H580, 1993.